Cannabis News

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(Frankfurt:D2EP) ("Phyto Extractions™, "Phyto" or the "Company") has secured a supply agreement for dried cannabis with a major Canadian License Holder. The supply agreement will provide upwards of 12,000 kgs of dried cannabis biomass over six months

Phyto Extractions Inc.'s, wholly owned Health Canada licensed subsidiary, Adastra Labs Inc. will leverage its agricultural scale extraction, formulation and product fulfillment capabilities to produce an estimated 1,500 kg of high-value cannabis concentrates. These concentrates will be incorporated into consumer-packaged goods under the Phyto Extractions™ brand, for distribution across Canada. Additionally, the scientific team at Phyto will make use of their industry-leading cryogenic ethanol and hydrocarbon extraction systems to efficiently produce distillate, with over 90% THC, shatter, full-spectrum shatter vaporizer cartridges and other hydrocarbon derivative products. These products will generate up to $74,985,000 in retail sales across Canada. (BC Cannabis Stores). Fulfillment of this supply agreement will represent 1/3 of the company's extraction capacity, allowing Phyto Extractions™ to continue to expand its operations and product lines with new brands and partners.

Phyto will be able to reduce its produced per gram cost by over 25% by acquiring the low-cost input cannabis. These savings will then be passed along to consumers. Aggressive price reductions at retail locations will facilitate substantial expansion to major Canadian cannabis markets, while consistent supply will support continual growth within existing product offerings.

"The security of supply at such an attractive price will allow Phyto Extractions™ to grow with increasing demand of it's already popular SKUs and expand its hydrocarbon extraction product offerings across the country at extremely competitive prices for retailers and consumers alike," said Donald Dinsmore, COO.

To learn more about Phyto Extractions™ and the team, please watch the following video:


https://youtu.be/pXWgR2MqZDY

About Phyto Extractions

Phyto Extractions™ is an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction and products, no cultivation), Sales (extracts, topicals, and edibles), and R&D through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc.

ON BEHALF OF THE BOARD Phyto Extractions INC. (CSE: XTRX)
Contact: Michael Forbes, President, CEO & Director (Chairman)
Phone: 778-715-5011
Email: michael@phytoextractions.ca

Forward-Looking Information:

This news release includes forward-looking information within the meaning of Canadian securities legislation, concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking information in this news release includes statements with respect of the proposed name change, proposed consolidation, the closing of the private placement and the use of proceeds thereof. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward looking information, including: (i) adverse market conditions; (ii) risks inherent in the cannabis extraction sector in general; (iii) inability to close the private placement for any reason, or in the amounts expected by the Company; and (iv) other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements. The CSE has not reviewed or approved of any contents of this news release.

SOURCE:Phyto Extractions Inc.



View source version on accesswire.com:
https://www.accesswire.com/655670/Phyto-Extractions-Secures-Biomass-Supply-Agreement

News Provided by ACCESSWIRE via QuoteMedia

adastra labs

Adastra Holdings


Keep reading...Show less
VIDEO — HEXO CEO: Aggressive Pursuit of Clean Balance Sheet Has Reset Company

VIDEO — HEXO CEO: Aggressive Pursuit of Clean Balance Sheet Has Reset Company

It’s been a seriously difficult period for Canadian cannabis operators over the past few years, with volatility prevailing as the status quo for companies in the market.

Charlie Bowman, president and CEO of HEXO (NASDAQ:HEXO,TSX:HEXO), understands that, and that’s why his first order of business after taking the helm at the company was to clean up its finances. He sees a better path ahead for HEXO now that it has restructured its assets and had its debt purchased by a fellow Canadian producer.

Bowman spoke at length with the Investing News Network (INN) about the downturn in Canadian cannabis stocks, HEXO’s NASDAQ listing status and its partnership with Tilray Brands (NASDAQ:TLRY,TSX:TLRY).

Keep reading...Show less
Avicanna Reports Q2 2022 Financial Statement

Avicanna Reports Q2 2022 Financial Statement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS

Avicanna Inc. (" Avicanna " or the " Company ") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, is pleased to announce the filing of its interim financial statements for the three-month period ending June 30, 2022 (" Q2 2022 ").

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Limited-Edition Pumpkin Spice CBD Wellness Gummies Arrive Just in Time for Fall As Martha Stewart CBD Expands Portfolio

New, classic fall flavor joins brand's best-selling lineup of CBD products

Today, Martha Stewart CBD unveiled the latest flavor in its CBD portfolio Pumpkin Spice CBD Wellness Gummies. Inspired by the most recognized flavor of the fall, these new gummies tap into the spirit of the season and are the perfect addition to consumers' favorite fall activities. These limited-edition gummies continue the expansion of the Martha Stewart CBD gummies lineup, which features some of the brands most popular items and flavors, including the Tropical Medley CBD Wellness Gummies™ and Harvest Medley CBD Wellness Gummies™.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
The Greenrose Holding Company Postpones Second Quarter 2022 Conference Call, Originally Scheduled for August 15, 2022 at 5:00 p.m. ET

The Greenrose Holding Company Postpones Second Quarter 2022 Conference Call, Originally Scheduled for August 15, 2022 at 5:00 p.m. ET

The Greenrose Holding Company Inc. (OTC: GNRS, GNRSW) ("Greenrose" or the "Company"), a multi-state grower and producer of cannabis brands and products announced that it will be postponing its scheduled conference call on Monday, August 15, 2022, at 5:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2022.

Greenrose is committed to reporting its second quarter 2022 financial results and providing an update on timing for the rescheduled conference call as soon as practicable. The Company expects to issue revised call details once confirmed.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Centurion Reports Results of AGSM

Centurion Minerals Ltd. (TSXV: CTN) ("Centurion", or the "Company") reports that shareholders approved all proposed management resolutions at its Annual General and Special Meeting ("AGSM") held August 12, 2022. Below are the approved resolutions:

  1. The number of Directors for the Company was set at four;
  2. The four members elected to the Board of Directors include: David G. Tafel, Jeremy Wright, Kenneth A. Cawkell, and Joseph Del Campo;
  3. Manning Elliot LLP, Chartered Accountants, was reappointed as auditor of the Company;
  4. The Company's New Long Term Incentive Plan was ratified;
  5. The Plan of Arrangement under section 288 of the Business Corporations Act (British Columbia) involving the Company and SpinCo. (The purpose of the Arrangement is to restructure the Company by creating SpinCo, which will become a reporting issuer in the Provinces of British Columbia and Alberta upon completion of the Arrangement. SpinCo will hold the Company's Cannabis Assets, as more fully set forth in the Management Circular. Centurion will retain its remaining assets and working capital and continue as a mineral exploration company.)

ABOUT CENTURION
Centurion Minerals Ltd. is a Canadian-based company with a focus on mineral asset development in the Americas. The Company's lead investment is its interest in the Ana Sofia Agri-Gypsum Fertilizer Project, and it is also reviewing additional prospective, precious mineral exploration projects.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Cannabis Weekly Round-Up: Earnings Season Continues with Trulieve, TerrAscend and Others

Cannabis Weekly Round-Up: Earnings Season Continues with Trulieve, TerrAscend and Others

A variety of cannabis companies shared their financial results this past trading week, offering investors a chance to inspect the health of the market.

Meanwhile, an international cannabis firm reported a new supply agreement covering key markets in Europe.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading...Show less

Latest Press Releases

Related News

×